Unbiased Analysis of Today's Healthcare Issues

IVI Model highlights ACR Conference

As reported in a Academy of Managed Care & Specialty Pharmacy newsletter, titled “Mathematical Model Aims to Improve Cost-Effectiveness of Rheumatology Treatment“, the Innovation and Value Initiative’s is highlighted from the American College of Rheumatology conference.  Here is an excerpt: Biological therapies for moderate to severe rheumatoid arthritis have significantly improved treatment and prognosis. However, […]

Read the rest of this entry »

What outcomes matter to patients with Rheumatoid Arthritis?

That is the question that the Outcome Measures in Rheumatology (OMERACT) Working Group attempted to answer. Specifically, the working group aimed to determine the core set of outcome domains for measuring the effectiveness of shared decision-making (SDM) interventions within clinical trials used to treat rheumatic diseases.  These diseases included osteoarthritis (OA), rheumatoid arthritis (RA), and psoriatic […]

Read the rest of this entry »

Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis

This is the title of my latest article in JMCP co-authored with Arijit Ganguli,  Yuri Sanchez Gonzalez, Jin Joo Shim, and Seth A. Seabury.  The paper’s abstract is below. BACKGROUND: There is considerable push to improve value in health care by simultaneously increasing quality while lowering or containing costs. However, for diseases that are best […]

Read the rest of this entry »